Literature DB >> 34039485

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis.

Rajiv Jalan1, Gennaro D'Amico2, Jonel Trebicka3, Richard Moreau4, Paolo Angeli5, Vicente Arroyo6.   

Abstract

Traditionally, the complications of cirrhosis, namely variceal bleeding, ascites and hepatic encephalopathy, were thought to result predominantly from circulatory dysfunction and altered organ perfusion arising as a result of portal hypertension. Over the past 20 years, large, international prospective studies have indicated the importance of systemic inflammation and organ immunopathology as additional determinants of organ dysfunction in cirrhosis, which not only manifests in the liver, brain, circulation and the kidneys, but also the immune system, gut, muscles, adrenal glands, reproductive organs, heart and lungs. This review provides an overview of the traditional and emerging concepts around the initiation and maintenance of organ dysfunction in cirrhosis and proposes a new paradigm based upon a better understanding of acute decompensation of cirrhosis. The interaction between the traditional concepts and the emerging perspectives remains a matter of great interest and the basis for future research.
Copyright © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute on chronic liver failure; Ascites; Cirrhosis; Hepatic encephalopathy; Infection; Inflammation; Varices

Mesh:

Year:  2021        PMID: 34039485     DOI: 10.1016/j.jhep.2021.01.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

Review 1.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

2.  Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Zhaohui Bai; Le Wang; Ran Wang; Meijuan Zou; Nahum Méndez-Sánchez; Fernando Gomes Romeiro; Gang Cheng; Xingshun Qi
Journal:  Hepatol Int       Date:  2022-09-01       Impact factor: 9.029

Review 3.  Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure.

Authors:  Martin S Schulz; Wenyi Gu; Andreas A Schnitzbauer; Jonel Trebicka
Journal:  Transpl Int       Date:  2022-03-17       Impact factor: 3.842

4.  New concepts and perspectives in decompensated cirrhosis.

Authors:  Rajiv Jalan; Gyongyi Szabo
Journal:  J Hepatol       Date:  2021-07       Impact factor: 30.083

5.  Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD).

Authors:  Harshavardhan Rao B; Priya Nair; Anoop K Koshy; S Krishnapriya; C R Greeshma; Rama P Venu
Journal:  Int J Hepatol       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.